Press Releases

Date	Title	Company
02-Jun-2021	BIOVECTRA Inc. Looks Inward for New Brand: It’s All About Care	Businesswire
02-Jun-2021	Synthetic Biology Market : Growth in research on synthetic drugs and vaccines	markets and markets
02-Jun-2021	UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility	Businesswire
02-Jun-2021	Vortex Biosciences, liquid biopsy for cancer diagnosis, announces experienced start-up leader Dr. Adrian Kinkaid as new CEO	Vortex Biosciences
02-Jun-2021	Virios Therapeutics Presents Phase 2a Fibromyalgia Trial Data on Efficacy Analyses of Key Secondary Endpoints at the EULAR European Congress of Rheumatology	Businesswire
02-Jun-2021	Immutep secures second European patent for Eftilagimod alpha, a soluble LAG-3 protein, in combination with a PD-1 pathway inhibitor	Immutep Limited
02-Jun-2021	Aptamer and PinotBio collaborate to develop new therapeutic drug conjugates	Aptamer
02-Jun-2021	Celltrion Healthcare presents positive one-year data for the first high-concentration, low- volume and citrate-free biosimilar adalimumab, YuflymaTM (CT-P17) in patients with rheumatoid arthritis at EULAR 2021	Celltrion Healthcare
02-Jun-2021	Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021	Businesswire
02-Jun-2021	As ASCO 2021 Spotlights Biomarkers, New InCrowd Data Shows 80% of US Oncologists Anticipate Broader Liquid Biomarkers Use, Despite Insurance Barriers	Businesswire
02-Jun-2021	Can-Fite to Present at BIO Digital International Convention & Conduct One-on-One Meetings with Potential Partners on June 10-18, 2021	Businesswire
02-Jun-2021	AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses	Businesswire
02-Jun-2021	Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets	Businesswire
02-Jun-2021	Single-dose Sputnik Light vaccine approved for use in Mauritius	Russian Direct Investment Fund
02-Jun-2021	Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) as First-Line Treatment for Unresectable Malignant Pleural Mesothelioma	Businesswire
02-Jun-2021	Bristol Myers Squibb Data at EULAR 2021 Highlight Commitment to Driving Advancements Across Multiple Immune-Mediated Rheumatic Diseases	Businesswire
02-Jun-2021	Sunnova Launches Solar + Storage Lease Service Offerings in Nine States	Businesswire
02-Jun-2021	Janssen presenta nuevos datos de cilta-cel, una CAR-T dirigida a BCMA, que muestran respuestas profundas y duraderas en pacientes con mieloma múltiple recidivante o refractario	Businesswire
02-Jun-2021	Global Cell Therapy Bioprocessing Market Forecast to 2028 - COVID-19 Impact and Analysis by Technology, Cell Type, End User, and Geography - ResearchAndMarkets.com	Businesswire
02-Jun-2021	Janssen meldet neue Daten für die gegen das BCMA gerichtete CAR-T-Therapie Cilta-cel, die ein tiefes und dauerhaftes Ansprechen bei Patienten mit rezidiviertem oder refraktärem multiplem Myelom zeigen	Businesswire